In two additional patients, it was only preceded by a recurrent SRSF2 and TET2 mutation, known to occur in normal individuals with clonal hematopoiesis (CH) and requiring additional driver mutations to transform to AML44. Here, TET2 is linked to cyclic hematopoiesis.